Table 3.

% Inhibition values of the synthesized lapatinib derivatives 6a–l over EGFR and HER2 kinases at 10 µM.

Cpd	% Kinase Inhibition at 10 µM
	EGFR	HER2
6a	98.79	74.72
6b	99.34	78.04
6c	99.32	89.99
6d	99.09	79.68
6e	67.27	8.78
6f	76.55	11.69
6g	91.80	43.06
6h	94.67	47.34
6i	97.65	87.16
6j	99.03	96.73
6k	98.64	91.16
6l	98.58	89.05